About
Looking for more information?
Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
Current price
$0.175
▾0.00 (0.00%)
Last trade: Invalid date GMT
Market cap
$554.91m
20 min delay
Investor Presentations
Principal Activity
PYC Therapeutics is combining its breakthrough CPP technology with a next-generation precision medicine known as Antisense Oligonucleotide therapeutics (ASOs). This combination of CPPs and ASOs creates precise, safe, and highly effective drugs (known as CPP-ASOs) targeting a range of genetic diseases.
Address
Northern Entrance, Perth Children's Hospital, 15 Hospital Ave, Nedlands WA 6009, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
-
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Support
Live Chat
Markets
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 19, 15 William St
Melbourne VIC 3000
Australia